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Abstract
Study objective: To garner a framework for combining community wastewater surveillance

with state clinical surveillance that influence confirmation of SARS-CoV-2 variants within the
community, and recommend how the flow of such research evidence could be expanded and
employed for public health response.

Design, setting, and participants: This work involved analyzing wastewater samples collected

weekly from 17 geographically resolved locations in Louisville/Jefferson County, Kentucky from
February 10 to November 29, 2021. Genomic surveillance and RT-qPCR platforms were used as
screening to identify SARS-CoV-2 in wastewater, and state clinical surveillance was used for
confirmation.

Main results: The results demonstrate increased epidemiological value of combining

community wastewater genomic surveillance and RT-qPCR with conventional case auditing
methods. The spatial scale and temporal frequency of wastewater sampling provides promising
sensitivity and specificity to be useful to gain public health screening insights about community
emergence, seeding, and spread.

Conclusions: Better national surveillance systems are needed for future pathogens and

variants, and wastewater-based genomic surveillance represents opportune coupling. This
paper presents current evidence that complementary wastewater and clinical testing is
enhanced cost-effectively when linked; making a strong case for a joint public health
framework. The findings suggest significant potential for rapid progress to be made in
extending this work to consider pathogens of interest as a whole within wastewater, which
could be examined in either a targeted fashion as we currently do with SARS-CoV-2 or in terms
of a global monitoring of all pathogens found, and developing evidence based public health
practice to best support community health.

Keywords: COVID-19; community health; sewer; local government; variant; wastewater based
epidemiology
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Thumbnail Box
What is already known on this subject?
The primary approach for the genomic surveillance of SARS-CoV-2 relies on the sequencing of
clinical COVID-19 samples. Variants of SARS-CoV-2 can also be tracked in community
wastewater.

What this study adds?
We propose that, for comprehensive community surveillance, the first line of community
pathogen screening should involve geographically-resolved wastewater samples collected at a
regular frequency and employ both Next Generation Sequencing (NGS) and RT-qPCR. These
results could then be compared with state clinical surveillance. This framework is a more
comprehensive and cost-effective approach for surveillance in practice to catch community
emergence, seeding, and spread.

Policy implications
Our results present a framework that could support the implementation of better surveillance
policies directed to solve future community pathogen and variant detection. We anticipate this
work can help public health officials implement rational community sampling schemes and
develop sensible coordination with other clinical surveillance. The utility of this for COVID-19
extends to many other infectious disease models and other public health hazards such as toxic
exposures.
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1. Introduction
Many communities across the United States and world are using quantitative reverse
transcription polymerase chain reaction (RT-qPCR) platforms to identify SARS-CoV-2 variants
largely due to the low cost and effort involved. However, this approach has several distinct
disadvantages. Most notably, there is often a lag in the availability of primers and probes once a
variant of concern is declared, PCR cannot always distinguish between variants, and there is the
loss of historical data about the wider range of mutations that may prove to be useful in posthoc analysis (Boudet et al. 2021; Yaniv et al. 2021). Both the sequencing of clinical samples and
community wastewater samples can further identify the circulating diversity of SARS-CoV-2
variants in an area (Izquierdo-Lara et al. 2020; Nemudryi et al. 2020; Fontenele et al. 2021; Jahn
et al. 2021). As one of the communities in the United States employing next-generation
sequencing (NGS) and comprehensive bioinformatic analysis of wastewater samples weekly for
9 months during the COVID-19 pandemic, Louisville /Jefferson County, Kentucky (USA) is
uniquely positioned to provide insights and recommendations for this coupled approach and
provide policy recommendations for other regions trying to implement genomic surveillance.
To further leverage the public health response value of this approach, we have applied this
genomic surveillance method with geographically-resolved wastewater sampling at 17 sites
across Louisville/Jefferson County (Yeager et al. 2021). The aim of this study was to present the
framework for combining community wastewater genomic surveillance with traditional clinical
surveillance that influence confirmation of SARS-CoV-2 variants within the community, and to
recommend how the flow of such research evidence could be expanded and employed for
public health response.

2. Methods
2.1. Wastewater sample collection and handling
Wastewater was collected as a 24-hour time-weighted composite sample at 17 sites in
Jefferson County, Kentucky, USA, from February 10 to November 29, 2021. Samples were
collected once a week. The sites are a combination of street line utility holes and pump stations
which are considered neighborhood or zip code level areas, and treatment centers covering
larger geographic areas (Yeager et al. 2021). Samples were transported on ice to the University
of Louisville for analysis by reverse transcription quantitative polymerase chain reaction
(Rouchka et al. 2021).
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2.2. Genomic surveillance
On a weekly basis, one sample for each site was submitted for sequencing, regardless of Ct
value. As of week 40 (November 22, 2021 sampling date), a total of N=646 samples have been
sequenced using NGS approaches. To enable high sensitivity, the samples were enriched for
SARS-CoV-2 nucleic acids using the Swift Biosciences SNAP protocol for SARS-CoV-2. Samples
were barcoded with the Swift Biosciences indexing kit and sequenced on an Illumina NextSeq
500 using the NextSeq Mid Output Kit v.5 at 300 cycles (2x150bp reads). The sequences were
then directly aligned to the SARS-CoV-2 reference genome assembly (NC_045512.2) using BWA
(Li 2013). Reads were then trimmed using Swift Biosciences primerclip (Addetia et al. 2020) to
remove the primer read regions to avoid variant calling within these regions. The BCFTools
mpileup (Li et al. 2009) utility was used to summarize the coverage of mapped reads and
detected variants. Variants occurring with a frequency >= 0.05 with at least five sequences
confirming the variant were filtered for further analysis. The pattern of mutations within each
sample were there compared to variants of concern (VOC), variants of interest (VOI), and
variants under monitoring (VUM). Those samples having at least 75% of mutations associated
with a specific variant were then marked as likely containing that variant. Results of this
analysis were available within the same week the sample was collected and were shared with
public county and state public health officials.
2.3. Ethics
The University of Louisville Institutional Review Board classified this project as Non-Human
Subjects Research (reference #: 717950).

3. Results and Discussion
The University of Louisville (UofL) has led the application of wastewater-based epidemiology
(WBE) as a partner to both Louisville Metro Public Health and Wellness (LMPHW) and to the
Kentucky Department of Public Health (DPH), beginning in May 2020. The initial focus of these
arrangements was on quantifying virus recovered in community and correctional facility
wastewater to help inform public health officials about intensity and spread of infection.
However, by February 2021, the work expanded to include full NGS at the UofL of the
recovered viral RNA fragments to arrive at probabilistic estimates of the likelihood of the
presence of variants of SARS-CoV-2 in community catchment areas across the
Louisville/Jefferson County, Kentucky area. The work included Centers for Disease Control and
Prevention (CDC) variants of concern (VOC) and variants of interest (VOI) as well as some
variants of attention but with no classification. The initial surveillance starting in February 2021
included: B.1.1.7, B.1.351, B.1.427, B.1.429, P.1, R.1, B.1.618, B.1.623, B.1.617.1, B.1.617.2,
B.1.617.3, and B.1.621. On July 5, 2021, we added C.37. On July 26, 2021, we added B.1.525,
B.1.526, and P.2. The Omicron (B.1.1.529) variant was added on November 30, 2021. Genomic
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sequencing results were typically available 4 days after wastewater sample collection. During
the initial four months of genomic analysis of the wastewater sampling, there were several
opportunities to explore the utility of this type of sampling at the community and regional level.
What emerged was a loose coupling between the wastewater analysis effort and the state’s
clinical genomic surveillance. Collaboration between state public health and academic centers
of excellence, formal or informal, presents an excellent opportunity for more complete
situational awareness and shared learning. Initiation of these collaborations often only involve
reaching out to the counterparts in the academic center or the state public health and sharing
ideas and needs. We saw this simple exchange of ideas between UofL and DPH develop into the
program that has produced successful scenarios, some of which we present here.
We discovered three scenarios that demonstrated complementary data from each activity.
First, because community wastewater sampling is a form of pooled testing, it effectively
samples 100% of the population connected to the wastewater system. Thus, it is far more likely
to detect an emerging variant than would be found through sparse sequencing of clinical
nasopharyngeal swabs. This was demonstrated in early April 2021 when our wastewater
genomic surveillance identified the Gamma (P.1) SARS-CoV-2 variant and UofL communicated
that to the county and state for geographically and demographically targeted public health
response. The variant was confirmed one week later when the first clinical case of that variant
within the same wastewater catchment area was identified. Since then, there have been
numerous comparisons between the catchment areas and clinical trends with this same
“Wastewater Community Screen and Clinical Confirm” approach. Our observation is similar to
Jahn et al. (2021), who reported detection of B.1.1.7 in wastewater treatment centers samples
in mid-December, and only later were these reported in clinically derived community data.
The second scenario occurred in late April 2021 when the DPH lab sequenced the clinical
samples from a rural senior living center outbreak reported to be caused by the B.1.1.316.1
(R.1) variant. The DPH requested a check with the UofL wastewater database to see if that
particular variant had been detected at any time anywhere in the county to better understand
spread risk while the United States government SARS-CoV-2 Interagency Group was making a
determination of its classification (Cavanaugh et al. 2021). Fortunately, there was no evidence
that R.1 had spread to Louisville/Jefferson County.
In the third instance, the B.1.526 variant was detected in one of the collection sites on August
26, 2021, a time at which Delta was dominate across all locations. Subsequent clinical
sequencing yielded a B.1.526 sample collected on September 17, 2021 from an adjacent zip
code (Supplement Figure A1). This illustrates the early detection capabilities of the wastewater
surveillance.
Since February 2021, weekly updates from UofL as academic partners are provided to LMPHW,
graphically representing the presence of wastewater variants within a rolling 4-week period
(Supplement Figure A2). On a weekly basis, it was not unusual for variants to appear or
disappear, and a moving 4-week period allowed stability as to the scale of variant presence.
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Moving reporting from a formal technical document to less than a dozen slides allowed rapid
understanding even among non-genomics and non-bioinformatics professionals and has been
an accepted and efficacious data deliverable format as received by LMPHW. While other
genomic work has focused on treatment centers wastewater samples (Nemudryi et al. 2020;
Crits-Christoph et al. 2021; Smyth et al. 2021), the benefit of our geographically-resolved
sampling design is that it allowed geographically-precise identification of variant emergence
and neighborhood spread on a weekly basis. Our results noted variants observed in smaller
wastewater catchment areas, such as neighborhood street line utility holes, were not uniformly
observed downstream at the associated treatment centers. Other genomic wastewater SARSCoV-2 sequencing work in the United States has also showed this similar utility of regular
temporal data (Nemudryi et al. 2020; Crits-Christoph et al. 2021; Fontenele et al. 2021; Smyth
et al. 2021).
Our work leveraged a foundational collaboration that existed prior to the pandemic between
the UofL, LMPHW, and the DPH, and the Louisville Metropolitan Sewer District. Our genomics
and bioinformatics laboratories have been involved in whole genome metagenomics in other
contexts, typically metagenomics populations within individuals. Financially, significant
components of the sampling and viral analysis were paid for through other mechanisms
including the American Rescue Plan and related federal public health funds. Additionally, UofL
is also concurrently funded by the NIH through Institutional Development Award (IDeA)
program, by the CDC for the wastewater sampling and testing, and by the Commonwealth of
Kentucky for wastewater monitoring of correctional facilities. These relationships provided the
project with strong communication channels with our state public health commissioner and the
CDC National Wastewater Surveillance System (NWSS) leadership that have enabled translation
from academic lab settings to sustainable ongoing deployment of the public health response
developed in this framework.
This work has helped answer important questions many communities in the United States and
around the world have about the utility of conducting wastewater surveillance as part of
genomic surveillance for infectious diseases. Over the course of the pandemic, one of the
greatest challenges has been the need to span fields of expertise and capability to arrive at
useful solutions. It is already showing some promise in Louisville/Jefferson County and our
results inform the roadmap for global adoption and long-term general capability. For example,
much of the data from the wastewater field has relied on PCR analysis of wastewater samples
gathered from wastewater centers or from college dormitories. Our framework (Figure 1)
provides valuable insights for other communities about the feasibility and value of NGS analysis
for SARS-CoV-2 variants in sampling scenarios that utilize smaller catchment areas. We
anticipate this work will help public health officials implement improved community sampling
schemes and develop coordination with other clinical surveillance. The utility of this approach
for COVID-19 certainly extends to many other infectious disease models and other public health
hazards such as toxic exposures.
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Figure 1. Framework for combining community wastewater genomic surveillance with state
clinical surveillance

4. Future Policy
This research has identified six key policy areas for exploration. These include:
1. The spatial scale of wastewater sampling that provides optimal sensitivity and specificity
to gain insights for public health response. For example, it may be less useful to know a
variant is present in a wastewater catchment area covering half the population than to
have neighborhood-scale data. Conversely, there is likely quickly diminishing value in
very small areas when cost and effort are considered.
2. The temporal frequency of community wastewater samples providing an optimal
balance of “early warning” and also information about seeding and spread. Some of this
issue has been addressed in the analysis of viral concentrations in community sampling.
However, the importance of identifying emerging variants that escape vaccination
creates a case for getting ahead of spread over time.
3. The coupling with clinical genomic surveillance has been anecdotally substantiated but
would be more useful in future situations and in other communities if there were a
systematic analysis of the relationship between spatiotemporal coverage of clinical
genomic surveillance and of wastewater genomic surveillance. For example, it may be
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possible to derive a useful level of clinical testing as a function of the wastewater
catchment area where a variant is first discovered. Conversely, a clinical case with a new
variant first identified at a location could trigger a series of nested catchment area
samples to be collected which is one of the classic approaches in “sewer tracing” dating
back to cholera.
4. Community seeding and spread of different variants is an area of analysis that could
improve understanding of possible entry points in communities and patterns of spread.
For example, initial analysis of historic data in Louisville/Jefferson County suggests
neighborhoods near our air logistics hub appear to be more likely to initially establish
new variants over time. It is possible our data could be connected to the larger database
for Kentucky and perhaps the country to provide insights into characteristics of places
that could inform new public health interventions.
5. The role vaccination plays in suppressing spread of variants is difficult to discern from
clinical testing alone. We propose wastewater samples to estimate levels of suppression
associated with vaccination coverage in an area to inform transmission rates in
communities of high and low vaccination coverage.
6. Determining at a high level what the cost-benefit tradeoffs are for different
configurations of wastewater and clinical genomics surveillance can be established using
Louisville/Jefferson County’s historic costs for both wastewater genomics and clinical
genomic testing.

5. Limitations
Wastewater samples may lack the RNA quality for longer sequence reads necessary to identify
multiple mutations in a single RNA amplicon. Wastewater detection relies on the capacity of a
pathogen to be shed into the wastewater, and pathogens or variants with altered shedding may
create new challenges for detection. Wastewater surveillance cannot provide data in residential
areas that are not served by municipal sewer systems and thus excludes some residences even
in an urban area such as Jefferson County. The limit of detection for wastewater surveillance
(i.e., the smallest number of infections in a community that can be detected in wastewater) is
not well established, thus wastewater surveillance cannot be used to determine whether a
community is actually free from SARS-CoV-2 infections and should be used in combination with
clinical results.
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6. Conclusion
This is the ideal time to improve public health surveillance system for pathogens, and
wastewater-based genomic surveillance represents a feasible and comprehensive complement
to established approaches. Further, the addition of genomic sequencing into the wastewater
surveillance framework may provide a more comprehensive assessment of regional viral
infection surveillance when compared to clinical testing alone. The value of this project to the
public health and clinical scientific community rests in our ability to produce compelling
evidence that COVID-19 genomic surveillance is cost-effectively enhanced through
complementary wastewater and clinical testing. There is important value in using a broad
perspective approach to identifying low abundance variants early from a few samples. A natural
extension of this work is in considering pathogens of interest as a whole within wastewater,
which could be examined in either a targeted fashion as we currently do with SARS-CoV-2 or in
terms of a global monitoring of all pathogens found, to develop evidence based public health
practice to best support community health.
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Figure A1. Clinical sequencing yielded a B.1.526 sample from an individual in the 40219 zip code (left) from a sample on 9/7/2021.
Examination of the wastewater samples indicated the presence of B.1.526 from a nearby wastewater collection site two week prior,
on 8/16/2021.
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Figure A2. August 2021, genomic surveillance of SARS-CoV-2 in wastewater data in Louisville /Jefferson County, Kentucky as
presented weekly by academic partners to Louisville Metro Health and Wellness.

